Nebraska Cancer Specialists Named GO2 for Lung Cancer Center of Excellence in Screening and Care
GO2 for Lung Cancer Recognizes Nebraska Cancer Specialists for Excellence in Early Detection and Comprehensive Lung Cancer Care
Omaha, NE — February 10th, 2026 — Nebraska Cancer Specialists (NCS) has been named a Center of Excellence (COE) by GO2 for Lung Cancer (GO2) in
both Lung Cancer Screening and Lung Cancer Care, recognizing the organization’s commitment to delivering patient-centered, evidence-based services across the full lung cancer continuum. An estimated 237,000 Americans are diagnosed with lung cancer each year, and the disease remains the leading cause of cancer-related deaths in the U.S. Early detection through low-dose CT (LDCT) screening and advances in treatment are transforming outcomes, helping more people live longer, higher-quality lives.
“We are proud to have Nebraska Cancer Specialists join the national network of GO2 for Lung Cancer Centers of Excellence,” said Joelle Fathi, Chief Healthcare Delivery Officer at GO2 for Lung Cancer. “Most people at risk for or living with lung cancer receive care close to home. Through the GO2 COE network, we support collaboration and knowledge sharing that brings the latest advancements in early detection, treatment, and care directly to local communities.”
Excellence in Screening and Care
As a Center of Excellence in Lung Cancer Screening, NCS provides low-dose CT scans for high-risk individuals, following evidence-based guidelines from leading organizations such as the American College of Radiology (ACR) and the National Comprehensive Cancer Network (NCCN). The program emphasizes patient-centered communication, shared decision-making, and coordinated follow-up.
As a Center of Excellence in Lung Cancer Care, NCS demonstrates access to comprehensive cancer services, including medical, radiation, and surgical oncology. Care is guided by clinical best practices and delivered through a multidisciplinary, team-based approach to ensure patients receive personalized, coordinated treatment.
“At Nebraska Cancer Specialists, we are dedicated to providing the highest quality care at every stage,” said Danielle Geiger, MSN, APRN-NP, AOCNP, Chief Operating Officer. “From early detection through advanced treatment, this recognition reflects our commitment to responsible screening, leading-edge therapies, and compassionate support for people in our communities facing lung cancer.”
ABOUT NEBRASKA CANCER SPECIALISTS
Nebraska Cancer Specialists (NCS) is the region’s leading independent physician-led oncology practice, providing comprehensive, compassionate cancer care close to home. Guided by its mission, committed to care, dedicated to discovery, NCS delivers advanced treatments, clinical research opportunities, and supportive services across multiple locations throughout Nebraska and Iowa. The practice offers expertise in medical oncology, hematology, radiation oncology, diagnostic services, and patient support, ensuring coordinated, personalized care for every patient. Through innovation, collaboration, and a deep commitment to the communities it serves, NCS works to improve outcomes and quality of life for people facing cancer. For more information, visit NebraskaCancer.com.
ABOUT GO2 FOR LUNG CANCER
GO2 for Lung Cancer relentlessly confronts lung cancer on every front, every day, for everyone. Founded by patients and survivors, GO2 is dedicated to increasing survival for those at risk, diagnosed, and living with lung cancer. For more information, visit go2.org and follow GO2 on social media.
